Form 4 for RMD ResMed|
Accepted 2024-10-09 00:00:00 ET · period of report 2024-10-08 · accession 0001127602-24-025369 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-09 | 2024-10-08 | RMD | Sandercock Brett | CFO | S - Sale | $233.47 | -1,000 | 95.8K | -1% | -$233.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2024-10-08 | S | D | 1,000 | $233.47 | 95,812 | D | — | — |